Liao et al. have reported that patients with ovarian cancer have HE4-positive urine, which is similar to serum samples, and detection of HE4 urine level can complement serum detection of ovarian cancer (Liao et al., 2015). The gene discussed is WFDC2; the disease is ovarian carcinoma.